Lehigh Valley Health Network

LVHN Scholarly Works
Department of Surgery

Abdominal Wall Reconstruction After Extirpation of a 140 Pound
Primary Ovarian Mucinous Adenocarcinoma: A Case Report.
Mamtha Raj MD
Lehigh Valley Health Network, Mamtha.Raj@lvhn.org

Sean J. Wallace MD
Lehigh Valley Hospital, sean.wallace@lvhn.org

Nathan F. Miller MD
Lehigh Valley Health Network, Nathan.Miller@lvhn.org

Randolph Wojcik MD
Lehigh Valley Health Network, Randolph.Wojcik@lvhn.org

Follow this and additional works at: https://scholarlyworks.lvhn.org/surgery
Part of the Surgery Commons

Published In/Presented At
Raj, M. Wallace, S. J., Miller, N. F., Wojcik, R. (2018, April 21). Abdominal Wall Reconstruction After
Extirpation of a 140 Pound Primary Ovarian Mucinous Adenocarcinoma: A Case Report. Poster Presented
at: 64th Annual Scientific Meeting of the Robert H. Ivy Society of Plastic Surgeons, Hershey, Pennsylvania.

This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion
in LVHN Scholarly Works by an authorized administrator. For more information, please contact
LibraryServices@lvhn.org.

Abdominal Wall Reconstruction After Extirpation of a 140 Pound Primary Ovarian Mucinous Adenocarcinoma: A Case Report
Mamtha Raj, MD, Sean J. Wallace, MD, Nathan F. Miller, MD, Randolph Wojcik Jr., MD
Department of Surgery – Division of Plastic and Reconstructive Surgery; Lehigh Valley Health Network; Allentown, Pa.

CASE REPORT

ABSTRACT
• Ovarian cancer is a feared diagnosis for women and clinicians alike.
• In this report, we present a case of a 71 year-old woman with a

massive and debilitating > 60 centimeter, 140 pound massive
primary ovarian mucinous adenocarcinoma. After extirpation, she
underwent extensive abdominal wall reconstruction utilizing a team
approach.
• Final pathology revealed stage IA grade 2 mucinous
adenocarcinoma of the ovary. No adjuvant therapies were indicated.
She is in clinical remission and has since resumed her normal daily
function.

INTRODUCTION
• Mucinous ovarian cancers constitute 15% of all ovarian neoplasms

and exist on a spectrum from benign to malignant. They typically
arise from the gastrointestinal tract, endometrium, and/or
endocervix.1
• Distinction between primary and metastatic mucinous ovarian
cancers is made on histologic examination and
immunohistochemical (IHC) staining. Common IHC markers include
CK7, CK20, CEA, CA19.9, CDX2, and CA-125. Of these, CEA and
CA-125 are commonly used in monitoring for recurrence of
disease.2
• Team approaches to massive tumor extirpations is essential, as
patients often require the expertise of various subspecialists
including, but not limited to gynecologic-oncologists, general
surgeons, and plastic and reconstructive surgeons.

• A 71-year-old female was transferred to a level I trauma and tertiary

care hospital with left leg and abdominal pain, refractory cellulitis, and
worsening dyspnea.
History of present illness revealed gradual and progressive weight
gain over 15 years time, decreasing cardiopulmonary function, and
loss of ambulatory independence.
Significant past medical history included deep venous thrombosis
(DVT), chronic bilateral lower extremity edema with recurrent
cellulitis, and morbid obesity (BMI: 65.3).
Examination revealed a morbidly obese female with:
Labored breathing requiring supplemental oxygen
Rotund, distended, tender, and cellulitic-appearing abdominal wall
with lichenification of the overlying skin.
Significant bilateral lower extremity edema, left > right
• Computed tomography revealed a massive > 60 cm intra-abdominal
mass with bilateral hydronephrosis (Figure 1). Ultrasounds of lower
extremities showed left femoral and popliteal DVTs.
• Pre-operative risk stratification and medical optimization were performed:
Low risk with Revised Cardiac Risk Index of 0.9%
Systemic anticoagulation and Greenfield filter placement for
recurrent DVT
• Operative exploration amongst Gynecologic-Oncology, General
Surgery, and Plastic & Reconstructive Surgery Services (Figure 2)
Intraoperative highlights:
Large volume skin resection in both horizontal (90 x 20 cm) and
vertical (60 x 20 cm) vectors

E xtirpation of massive > 60 cm, 140 pound ovarian mass (Figure 3)
Completion hysterectomy, bilateral salpingo-oophorectomy,
omentectomy, peritoneal stripping, bilateral inguinal
lymphadenectomy, and appendectomy
Excision of severely attenuated abdominal wall fascia and
reconstruction of posterior rectus sheath with an inlay biologic
uncoated mesh followed by an overlay of biologic coated mesh
(Figure 4)
Complex closure of vertical and horizontal skin components over
drains (Figure 5)
Secondary to massive volume shifts, a large volume of crystalloids,
colloids, and blood products were administered along with vasopressors
• Post-operatively
Patient remained intubated and monitored in the intensive care unit
due to hemodynamic lability.
On post-operative day #20, she was discharged to a skilled nursing
facility

RESULTS
• Pathology revealed a stage IA grade 2 mucinous adenocarcinoma of

the ovary.
No evidence of metastatic carcinoma
Tumor weight and dimension: 140 pounds; 63 x 41 x 40 cm
Left adnexal specimen positivity for immunohistochemical markers
CK7 and CK20
• She was followed as an outpatient by all involved surgical services.
Images have been included from her 3 month and 12 month visits.
(Figure 6)

C
 A-125 and CEA levels provide evidence of her clinical remission
No dehiscence or wound healing problems arose
She has returned to her daily activities
• No adjuvant therapies (chemotherapy or radiation) were required

DISCUSSION
• We present a patient with who was incidentally discovered to have a

massive abdominopelvic tumor. Extirpation and abdominal wall
reconstruction were performed with great improvement in the
patient’s health, ambulatory status, and reclamation of her
independence.
• Pathology revealed stage IA grade 2 mucinous adenocarcinoma of
the ovary that was negative for metastatic disease. A review of the
literature demonstrates that primary ovarian mucinous adenocarcinomas
have been described, but most reported range larger in size (> 10
cm)3. To our knowledge, this case represents one of the larger primary
ovarian mucinous adenocarcinoma extirpations to date.
• The patient’s positivity for CK7 and CK20 confirm the diagnosis of
primary ovarian mucinous adenocarcinoma, while her normal levels of
CEA and CA-125 signify her clinical remission.
• As expected, recurrent or metastatic disease is associated with poorer
prognoses and shorter 5-year survival expectancies. As such, it is our
hope that presenting this experience will raise awareness of these
spectrum of diseases and allow for earlier diagnoses and treatments,
as well as exemplify the virtues of a team-based approach in the
successful reconstruction of the abdominal wall.
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Figure 1: Computed tomography of abdomen &
pelvis showing massive intra-abdominal mass and
bilateral hydronephrosis.

Figure 2: Pre-operative photograph demonstrating left
lateral decubitus positioning that was used for initial tumor
removal.

Figure 3: Intraoperative photograph immediately after
extirpation of the tumor.

Figure 4: Intraoperative photograph showing
extreme redundancy and attenuation of
abdominal wall fascia after tumor extirpation.

Figure 5: A. Wounds on postoperative day
#2 with patient in supine position from both
(A) anterior and (B) lateral views

